We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy

Advertisement

Analysis of SARS-CoV-2 Immune Response Bodes Well for Vaccine Development

News   May 18, 2020 | Original story from La Jolla Institute for Immunology.

 
Analysis of SARS-CoV-2 Immune Response Bodes Well for Vaccine Development

The researchers tested over 3,000 virus fragments to determine whether they are recognized by the human immune system. Credit: La Jolla Institute for Immunology.

 
 
Advertisement
 

RELATED ARTICLES

Trial Investigates Unique Formulation of Ibuprofen as Treatment for COVID-19 Respiratory Complication

News

A trial is investigating a unique formulation of ibuprofen as a treatment for severe acute respiratory distress syndrome (ARDS), a complication of COVID-19.

READ MORE

Scouring Microbial Metabolic Pathways in the Pursuit of New Therapeutics

News

In a new study, researchers at the Centre for Genomic Regulation (CRG), in Barcelona, describe a new method for determining active metabolic pathways in microbes using cutting-edge techniques from genomics and proteomics.

READ MORE

Resistance Genes to Latest Generation of Antibiotics Are Widespread

News

Genes representing yet another method of antibiotic resistance are widespread in bacteria that live in the soil and on people, according to a new study.

READ MORE

 

Like what you just read? You can find similar content on the communities below.

Biopharma Immunology & Microbiology

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE